Hovilpri (pritelivir) in Refractory mucocutaneous herpes simplex virus infection in immunocompromised adults: Executive summary: Burden of Refractory mucocutaneous herpes simplex virus infection in immunocompromised adults | Evicenter
This page has moved to https://www.evicenter.com/drugs/hovilpri--refractory-mucocutaneous-herpes-simplex-virus-infection-in-immunocompromised-adults/executive-summary/disease-burden.